|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 18703825.2 (espacenet) (Federated) (European Patent Register), 20180130 | Patent/reg. no. and date | DK/EP 3576716, 20230621 | Publication date | 20191211 | Priority no. and date | GB 201701583, 20170131 | EP pub. no. and date |
EP 3576716 20191211 | Effective date | | Applicant/owner | MC2 Therapeutics Limited, 1A Guildford Business Park
Guildford GU2 8XG, GB | Applicant ref. no. | | Inventor | CRUTCHLEY, Nigel, c/o Drug Delivery Solutions Limited James House Emlyn Lane
Leatherhead Surrey KT22 7EP, GB, GEORGIOU, Michelle, c/o Drug Delivery Solutions Limited James House Emlyn Lane
Leatherhead Surrey KT22 7EP, GB | Representative | | Opponent | | IPC Class | A61K 31/69 (2006.01) | Title | TOPICAL COMPOSITION | Int. application no. | GB2018050263 | Int. publication no. | WO2018142117 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |